Venture Global on track to become top US LNG company if CP2 project approved — Positive
VG Reuters — May 22, 2025Venture Global is poised to become the largest U.S. liquefied natural gas company by next year if it proceeds with its CP2 project in Louisiana and continues overproduction at its existing plants, according to LSEG data and company statements.

Datavault AI CEO Nathaniel Bradley to Speak at Beyond Expo 2025 on AI Agents and NIL Monetization — Neutral
DVLT Business Wire — May 22, 2025BEAVERTON, Ore.--(BUSINESS WIRE)--Datavault AI CEO Nathaniel Bradley to Speak at Beyond Expo 2025 on AI Agents and NIL Monetization.

Atour Lifestyle Holdings Limited Reports First Quarter of 2025 Unaudited Financial Results — Neutral
ATAT GlobeNewsWire — May 22, 2025SHANGHAI, China, May 22, 2025 (GLOBE NEWSWIRE) -- Atour Lifestyle Holdings Limited (“Atour” or the “Company”) (NASDAQ: ATAT), a leading hospitality and lifestyle company in China, today announced its unaudited financial results for the first quarter ended March 31, 2025.

Amplify Energy to Participate in the 2025 Louisiana Energy Conference — Neutral
AMPY GlobeNewsWire — May 22, 2025HOUSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Amplify Energy Corp. (“Amplify” or the “Company”) (NYSE: AMPY) announced today that the Company will be participating in the 2025 Louisiana Energy Conference on Wednesday, May 28th at the Four Seasons in New Orleans, LA.

Instil Bio and ImmuneOnco Announced the Phase 2 Trial in First-line NSCLC of IMM2510/AXN-2510 (‘2510), a PD-L1xVEGF Bispecific Antibody, in Combination with Chemotherapy in China is on Track to Complete Enrollment in Q3 2025; Initial Results Anticipated in 2H 2025 — Neutral
TIL GlobeNewsWire — May 22, 2025Phase 3 trial of ‘2510 in combination with chemotherapy in first-line NSCLC anticipated to start in mid-2026 in China, subject to regulatory discussions

Atour Lifestyle Holdings Limited Announces Dividend and Share Repurchase Program — Neutral
ATAT GlobeNewsWire — May 22, 2025SHANGHAI, May 22, 2025 (GLOBE NEWSWIRE) -- Atour Lifestyle Holdings Limited (“Atour” or the “Company”) (NASDAQ: ATAT), a leading hospitality and lifestyle company in China, today announced that as part of its commitment to enhancing shareholder value, the Board of Directors (the “Board”) has (i) declared a dividend under its three-year annual dividend policy (the “Annual Dividend Policy”) adopted in August 2024, and (ii) authorized a three-year share repurchase program of up to US$400 million (the “Share Repurchase Program”).

RETRANSMISSION: HIVE Digital Technologies Celebrates Record 9.5 EH/s Milestone, Driving Shareholder Value on Path to 25 EH/s by 2025 — Neutral
HIVE Newsfile Corp — May 22, 2025This news release constitutes a "designated news release" for the purposes of the Company's amended and restated prospectus supplement dated May 14, 2025 to its short form base shelf prospectus dated September 11, 2024. San Antonio, Texas--(Newsfile Corp. - May 22, 2025) - HIVE Digital Technologies Ltd.

Marriott International Announces Global Launch of New Regional Collection Brand: Series by Marriott™ — Neutral
MAR PRNewsWire — May 22, 2025Company Signs Founding Deal with Concept Hospitality Private Limited in India to Affiliate The Fern Brands with Series by Marriott BETHESDA, Md. , May 22, 2025 /PRNewswire/ -- Marriott International, Inc. (Nasdaq: MAR) today announced the global launch of its new collection brand for the midscale and upscale lodging segments—Series by Marriott™—as the company continues to expand its lodging offerings around the world.

Waterdrop Inc. to Report First Quarter 2025 Financial Results on June 5, 2025 — Neutral
WDH PRNewsWire — May 22, 2025BEIJING , May 21, 2025 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2025, before U.S. markets open on Thursday, June 5, 2025. Waterdrop's management team will hold a conference call on June 5, 2025 at 8:00 AM U.S. Eastern Time (8:00 PM Beijing/Hong Kong Time on the same day) to discuss the financial results.

New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis — Neutral
AUPH Business Wire — May 22, 2025ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis.

Dorian LPG Ltd. Announces Fourth Quarter and Fiscal Year 2025 Financial Results — Neutral
LPG Business Wire — May 22, 2025STAMFORD, Conn.--(BUSINESS WIRE)--Dorian LPG Ltd. (NYSE: LPG) (the “Company,” “Dorian LPG,” “we,” and “our”), a leading owner and operator of modern very large gas carriers (“VLGCs”), today reported its financial results for the three months and fiscal year ended March 31, 2025. Key Recent Developments Declared an irregular cash dividend of $0.50 per share of the Company's common stock totaling $21.3 million to be paid on or about May 30, 2025 to all shareholders of record as of the close of bu.

BeiGene Presents Pioneering Cancer Research at ASCO 2025 – Redefining Treatment Across Hematology and Solid Tumors — Neutral
ONC Business Wire — May 22, 2025SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Ltd., today announced it will share 23 abstracts featuring new data across its hematology and solid tumor portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL, May 30 – June 3, 2025. With two abstracts selected for rapid oral presentation, these data reflect the Company's vision to address cancer.

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference — Neutral
AMPH Accesswire — May 22, 2025RANCHO CUCAMONGA, CA / ACCESS Newswire / May 22, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Jacob Liawatidewi, EVP of Corporate Administration, will be participating in an Analyst-Moderated fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5th, 2025, at 2:00 pm ET. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com.

Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection — Neutral
PSNL Business Wire — May 22, 2025FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced multiple presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting next week in Chicago, Illinois. The presentations feature new data from clinical studies utilizing the NeXT Personal® ultrasensitive ctDNA assay for residual and recurrent cancer detection. “These studies continue to expand the clinical data for NeXT Personal into new areas, in.

The UK government is on track and focusing on growth, says Barclays CEO — Positive
BCS CNBC International TV — May 22, 2025C.S. Venkatakrishnan, Barclays' group chief executive, discusses the global economy, the bank's business outlook, the U.K. economy, M&A and more from the Barclays Leadership Conference in London.

NET Power Looks More Attractive Now, Yet It Needs More Time (And Money) — Neutral
NPWR Seeking Alpha — May 22, 2025NET Power offers a unique clean energy solution with top-tier investors and Rice family leadership, but faces increased costs and project delays. A sharp stock sell-off followed negative earnings and a near doubling of cost estimates for the Project Permian, raising financing and execution concerns. Valuation now hovers below net cash, providing downside protection, yet increased capital needs, delays, and execution risks remain, as the company targets 2029 for commercial launch.

The Gross Law Firm Notifies Shareholders of Digimarc Corporation(DMRC) of a Class Action Lawsuit and an Upcoming Deadline — Neutral
DMRC PRNewsWire — May 22, 2025NEW YORK , May 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Digimarc Corporation (NASDAQ: DMRC). Shareholders who purchased shares of DMRC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Lost Money on Iovance Biotherapeutics, Inc.(IOVA)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm — Neutral
IOVA PRNewsWire — May 22, 2025NEW YORK , May 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA). Shareholders who purchased shares of IOVA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Contact The Gross Law Firm by July 8, 2025 Deadline to Join Class Action Against Compass Group Diversified Holdings, LLC(CODI) — Neutral
CODI PRNewsWire — May 22, 2025NEW YORK , May 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Compass Group Diversified Holdings, LLC (NYSE: CODI). Shareholders who purchased shares of CODI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Solaris Energy Infrastructure, Inc.(SEI) Shareholders — Neutral
SEI PRNewsWire — May 22, 2025NEW YORK , May 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Solaris Energy Infrastructure, Inc. (NYSE: SEI). Shareholders who purchased shares of SEI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
